Illinois 2025-2026 Regular Session

Illinois Senate Bill SB1875 Compare Versions

Only one version of the bill is available at this time.
OldNewDifferences
11 104TH GENERAL ASSEMBLY State of Illinois 2025 and 2026 SB1875 Introduced 2/5/2025, by Sen. Mike Porfirio SYNOPSIS AS INTRODUCED: 720 ILCS 648/25720 ILCS 649/15720 ILCS 649/30 Amends the Methamphetamine Precursor Control Act. Provides that each targeted methamphetamine precursor package shall contain no more than 3,600 (rather than 3,000) milligrams of ephedrine or pseudoephedrine, their salts or optical isomers, or salts of optical isomers. Deletes a provision which specifies that no retail distributor operating a pharmacy, and no pharmacist or pharmacy technician, shall knowingly distribute to a single person more than 2 targeted packages in a single retail transaction. Amends the Methamphetamine Precursor Tracking Act. Provides that, on and after October 1, 2025, any manufacturer of products containing methamphetamine precursors sold in or brought into the State must, on a monthly basis, pay fees to the Central Repository. Provides that the Central Repository shall be responsible for setting the fee levels required. Provides that at the request of the Illinois State Police, manufacturers required to pay fees shall be required to provide written documentation demonstrating that they have paid such fees. Provides that the sale of methamphetamine precursors in or brought into the State by a manufacturer who has failed to pay fees required by the provision is guilty of a petty offense and subject to a fine of $500 for a first offense; $1,000 for a second offense occurring within 3 years of the first offense; and $5,000 for a third or subsequent offense occurring within 3 years of the prior offenses. Effective immediately. LRB104 09441 RLC 19501 b A BILL FOR 104TH GENERAL ASSEMBLY State of Illinois 2025 and 2026 SB1875 Introduced 2/5/2025, by Sen. Mike Porfirio SYNOPSIS AS INTRODUCED: 720 ILCS 648/25720 ILCS 649/15720 ILCS 649/30 720 ILCS 648/25 720 ILCS 649/15 720 ILCS 649/30 Amends the Methamphetamine Precursor Control Act. Provides that each targeted methamphetamine precursor package shall contain no more than 3,600 (rather than 3,000) milligrams of ephedrine or pseudoephedrine, their salts or optical isomers, or salts of optical isomers. Deletes a provision which specifies that no retail distributor operating a pharmacy, and no pharmacist or pharmacy technician, shall knowingly distribute to a single person more than 2 targeted packages in a single retail transaction. Amends the Methamphetamine Precursor Tracking Act. Provides that, on and after October 1, 2025, any manufacturer of products containing methamphetamine precursors sold in or brought into the State must, on a monthly basis, pay fees to the Central Repository. Provides that the Central Repository shall be responsible for setting the fee levels required. Provides that at the request of the Illinois State Police, manufacturers required to pay fees shall be required to provide written documentation demonstrating that they have paid such fees. Provides that the sale of methamphetamine precursors in or brought into the State by a manufacturer who has failed to pay fees required by the provision is guilty of a petty offense and subject to a fine of $500 for a first offense; $1,000 for a second offense occurring within 3 years of the first offense; and $5,000 for a third or subsequent offense occurring within 3 years of the prior offenses. Effective immediately. LRB104 09441 RLC 19501 b LRB104 09441 RLC 19501 b A BILL FOR
22 104TH GENERAL ASSEMBLY State of Illinois 2025 and 2026 SB1875 Introduced 2/5/2025, by Sen. Mike Porfirio SYNOPSIS AS INTRODUCED:
33 720 ILCS 648/25720 ILCS 649/15720 ILCS 649/30 720 ILCS 648/25 720 ILCS 649/15 720 ILCS 649/30
44 720 ILCS 648/25
55 720 ILCS 649/15
66 720 ILCS 649/30
77 Amends the Methamphetamine Precursor Control Act. Provides that each targeted methamphetamine precursor package shall contain no more than 3,600 (rather than 3,000) milligrams of ephedrine or pseudoephedrine, their salts or optical isomers, or salts of optical isomers. Deletes a provision which specifies that no retail distributor operating a pharmacy, and no pharmacist or pharmacy technician, shall knowingly distribute to a single person more than 2 targeted packages in a single retail transaction. Amends the Methamphetamine Precursor Tracking Act. Provides that, on and after October 1, 2025, any manufacturer of products containing methamphetamine precursors sold in or brought into the State must, on a monthly basis, pay fees to the Central Repository. Provides that the Central Repository shall be responsible for setting the fee levels required. Provides that at the request of the Illinois State Police, manufacturers required to pay fees shall be required to provide written documentation demonstrating that they have paid such fees. Provides that the sale of methamphetamine precursors in or brought into the State by a manufacturer who has failed to pay fees required by the provision is guilty of a petty offense and subject to a fine of $500 for a first offense; $1,000 for a second offense occurring within 3 years of the first offense; and $5,000 for a third or subsequent offense occurring within 3 years of the prior offenses. Effective immediately.
88 LRB104 09441 RLC 19501 b LRB104 09441 RLC 19501 b
99 LRB104 09441 RLC 19501 b
1010 A BILL FOR
1111 SB1875LRB104 09441 RLC 19501 b SB1875 LRB104 09441 RLC 19501 b
1212 SB1875 LRB104 09441 RLC 19501 b
1313 1 AN ACT concerning criminal law.
1414 2 Be it enacted by the People of the State of Illinois,
1515 3 represented in the General Assembly:
1616 4 Section 5. The Methamphetamine Precursor Control Act is
1717 5 amended by changing Section 25 as follows:
1818 6 (720 ILCS 648/25)
1919 7 Sec. 25. Pharmacies.
2020 8 (a) No targeted methamphetamine precursor may be knowingly
2121 9 distributed through a pharmacy, including a pharmacy located
2222 10 within, owned by, operated by, or associated with a retail
2323 11 distributor unless all terms of this Section are satisfied.
2424 12 (b) Any targeted methamphetamine precursor other than a
2525 13 convenience package or a liquid, including but not limited to
2626 14 any targeted methamphetamine precursor in liquid-filled
2727 15 capsules, shall: be packaged in blister packs, with each
2828 16 blister containing not more than 2 dosage units, or when the
2929 17 use of blister packs is technically infeasible, in unit dose
3030 18 packets. Each targeted package shall contain no more than
3131 19 3,600 3,000 milligrams of ephedrine or pseudoephedrine, their
3232 20 salts or optical isomers, or salts of optical isomers.
3333 21 (c) The targeted methamphetamine precursor shall be stored
3434 22 behind the pharmacy counter and distributed by a pharmacist or
3535 23 pharmacy technician licensed under the Pharmacy Practice Act,
3636
3737
3838
3939 104TH GENERAL ASSEMBLY State of Illinois 2025 and 2026 SB1875 Introduced 2/5/2025, by Sen. Mike Porfirio SYNOPSIS AS INTRODUCED:
4040 720 ILCS 648/25720 ILCS 649/15720 ILCS 649/30 720 ILCS 648/25 720 ILCS 649/15 720 ILCS 649/30
4141 720 ILCS 648/25
4242 720 ILCS 649/15
4343 720 ILCS 649/30
4444 Amends the Methamphetamine Precursor Control Act. Provides that each targeted methamphetamine precursor package shall contain no more than 3,600 (rather than 3,000) milligrams of ephedrine or pseudoephedrine, their salts or optical isomers, or salts of optical isomers. Deletes a provision which specifies that no retail distributor operating a pharmacy, and no pharmacist or pharmacy technician, shall knowingly distribute to a single person more than 2 targeted packages in a single retail transaction. Amends the Methamphetamine Precursor Tracking Act. Provides that, on and after October 1, 2025, any manufacturer of products containing methamphetamine precursors sold in or brought into the State must, on a monthly basis, pay fees to the Central Repository. Provides that the Central Repository shall be responsible for setting the fee levels required. Provides that at the request of the Illinois State Police, manufacturers required to pay fees shall be required to provide written documentation demonstrating that they have paid such fees. Provides that the sale of methamphetamine precursors in or brought into the State by a manufacturer who has failed to pay fees required by the provision is guilty of a petty offense and subject to a fine of $500 for a first offense; $1,000 for a second offense occurring within 3 years of the first offense; and $5,000 for a third or subsequent offense occurring within 3 years of the prior offenses. Effective immediately.
4545 LRB104 09441 RLC 19501 b LRB104 09441 RLC 19501 b
4646 LRB104 09441 RLC 19501 b
4747 A BILL FOR
4848
4949
5050
5151
5252
5353 720 ILCS 648/25
5454 720 ILCS 649/15
5555 720 ILCS 649/30
5656
5757
5858
5959 LRB104 09441 RLC 19501 b
6060
6161
6262
6363
6464
6565
6666
6767
6868
6969 SB1875 LRB104 09441 RLC 19501 b
7070
7171
7272 SB1875- 2 -LRB104 09441 RLC 19501 b SB1875 - 2 - LRB104 09441 RLC 19501 b
7373 SB1875 - 2 - LRB104 09441 RLC 19501 b
7474 1 or by an agent of the pharmacist or pharmacy technician.
7575 2 (d) Any retail distributor operating a pharmacy, and any
7676 3 pharmacist or pharmacy technician involved in the transaction
7777 4 or transactions, shall ensure that any person purchasing,
7878 5 receiving, or otherwise acquiring the targeted methamphetamine
7979 6 precursor complies with subsection (a) of Section 20 of this
8080 7 Act.
8181 8 (e) Any retail distributor operating a pharmacy, and any
8282 9 pharmacist or pharmacy technician involved in the transaction
8383 10 or transactions, shall verify that:
8484 11 (1) The person purchasing, receiving, or otherwise
8585 12 acquiring the targeted methamphetamine precursor is 18
8686 13 years of age or older and resembles the photograph of the
8787 14 person on the government-issued identification presented
8888 15 by the person; and
8989 16 (2) The name entered into the log referred to in
9090 17 subsection (a) of Section 20 of this Act corresponds to
9191 18 the name on the government-issued identification presented
9292 19 by the person.
9393 20 (f) The logs referred to in subsection (a) of Section 20 of
9494 21 this Act shall be kept confidential, maintained for not less
9595 22 than 4 years, and made available for inspection and copying by
9696 23 any law enforcement officer upon request of that officer.
9797 24 These logs shall be kept in an electronic format as required by
9898 25 the Methamphetamine Precursor Tracking Act.
9999 26 (g) No retail distributor operating a pharmacy, and no
100100
101101
102102
103103
104104
105105 SB1875 - 2 - LRB104 09441 RLC 19501 b
106106
107107
108108 SB1875- 3 -LRB104 09441 RLC 19501 b SB1875 - 3 - LRB104 09441 RLC 19501 b
109109 SB1875 - 3 - LRB104 09441 RLC 19501 b
110110 1 pharmacist or pharmacy technician, shall knowingly distribute
111111 2 any targeted methamphetamine precursor to any person under 18
112112 3 years of age.
113113 4 (h) (Blank). No retail distributor operating a pharmacy,
114114 5 and no pharmacist or pharmacy technician, shall knowingly
115115 6 distribute to a single person more than 2 targeted packages in
116116 7 a single retail transaction.
117117 8 (i) No retail distributor operating a pharmacy, and no
118118 9 pharmacist or pharmacy technician, shall knowingly distribute
119119 10 to a single person in any 30-day period products containing
120120 11 more than a total of 7,500 milligrams of ephedrine or
121121 12 pseudoephedrine, their salts or optical isomers, or salts of
122122 13 optical isomers.
123123 14 (j) A pharmacist or pharmacy technician may distribute a
124124 15 targeted methamphetamine precursor to a person who is without
125125 16 a form of identification specified in paragraph (1) of
126126 17 subsection (a) of Section 20 of this Act only if all other
127127 18 provisions of this Act are followed and either:
128128 19 (1) the person presents a driver's license issued
129129 20 without a photograph by the State of Illinois pursuant to
130130 21 the Illinois Administrative Code, Title 92, Section
131131 22 1030.90(b)(1) or 1030.90(b)(2); or
132132 23 (2) the person is known to the pharmacist or pharmacy
133133 24 technician, the person presents some form of
134134 25 identification, and the pharmacist or pharmacy technician
135135 26 reasonably believes that the targeted methamphetamine
136136
137137
138138
139139
140140
141141 SB1875 - 3 - LRB104 09441 RLC 19501 b
142142
143143
144144 SB1875- 4 -LRB104 09441 RLC 19501 b SB1875 - 4 - LRB104 09441 RLC 19501 b
145145 SB1875 - 4 - LRB104 09441 RLC 19501 b
146146 1 precursor will be used for a legitimate medical purpose
147147 2 and not to manufacture methamphetamine.
148148 3 (k) When a pharmacist or pharmacy technician distributes a
149149 4 targeted methamphetamine precursor to a person according to
150150 5 the procedures set forth in this Act, and the pharmacist or
151151 6 pharmacy technician does not have access to a working cash
152152 7 register at the pharmacy counter, the pharmacist or pharmacy
153153 8 technician may instruct the person to pay for the targeted
154154 9 methamphetamine precursor at a cash register located elsewhere
155155 10 in the retail establishment, whether that register is operated
156156 11 by a pharmacist, pharmacy technician, or other employee or
157157 12 agent of the retail establishment.
158158 13 (Source: P.A. 96-50, eff. 10-21-09; 97-670, eff. 1-19-12.)
159159 14 Section 10. The Methamphetamine Precursor Tracking Act is
160160 15 amended by changing Sections 15 and 30 as follows:
161161 16 (720 ILCS 649/15)
162162 17 Sec. 15. General provisions.
163163 18 (a) Structure. There is established a statewide precursor
164164 19 tracking program coordinated and administered by the Illinois
165165 20 State Police to track purchases of targeted methamphetamine
166166 21 precursors across multiple locations for the purposes stated
167167 22 in Section 5 of this Act. Every covered pharmacy must comply
168168 23 with this Act. The tracking program created by this Act shall
169169 24 be the sole methamphetamine precursor tracking program in
170170
171171
172172
173173
174174
175175 SB1875 - 4 - LRB104 09441 RLC 19501 b
176176
177177
178178 SB1875- 5 -LRB104 09441 RLC 19501 b SB1875 - 5 - LRB104 09441 RLC 19501 b
179179 SB1875 - 5 - LRB104 09441 RLC 19501 b
180180 1 Illinois.
181181 2 (b) Transmission of electronic transaction records. Unless
182182 3 otherwise provided in this Act, each time a covered pharmacy
183183 4 distributes a targeted methamphetamine precursor to a
184184 5 recipient, the pharmacy shall transmit an electronic
185185 6 transaction record to the Central Repository.
186186 7 (c) Notification. The Illinois Department of Financial and
187187 8 Professional Regulation shall notify pharmacies seeking
188188 9 licensure in Illinois of their obligation to comply with the
189189 10 requirements of this Act.
190190 11 (d) Electronic transmission. Starting on the effective
191191 12 date of this Act and continuing thereafter, covered pharmacies
192192 13 shall transmit all electronic transaction records as required
193193 14 by this Act.
194194 15 (e) Funding.
195195 16 (1) On and after October 1, 2025, any manufacturer of
196196 17 products containing methamphetamine precursors sold in or
197197 18 brought into this State must, on a monthly basis, pay fees
198198 19 to the Central Repository.
199199 20 (2) The Central Repository shall be responsible for
200200 21 setting the fee levels required under paragraph (1).
201201 22 (3) At the request of the Illinois State Police,
202202 23 manufacturers required to pay fees under paragraph (1)
203203 24 shall be required to provide written documentation
204204 25 demonstrating that they have paid such fees.
205205 26 (4) The sale of methamphetamine precursors in or
206206
207207
208208
209209
210210
211211 SB1875 - 5 - LRB104 09441 RLC 19501 b
212212
213213
214214 SB1875- 6 -LRB104 09441 RLC 19501 b SB1875 - 6 - LRB104 09441 RLC 19501 b
215215 SB1875 - 6 - LRB104 09441 RLC 19501 b
216216 1 brought into this State by a manufacturer who has failed
217217 2 to pay fees required under paragraph (1) shall be
218218 3 considered a violation of this Section and shall subject
219219 4 the manufacturer to the penalties outlined in subsection
220220 5 (c) of Section 30.
221221 6 (5) Funding for the tracking program shall be provided
222222 7 by the Illinois State Police drawing upon federal and
223223 8 State grant money and other available sources.
224224 9 (Source: P.A. 97-670, eff. 1-19-12.)
225225 10 (720 ILCS 649/30)
226226 11 Sec. 30. Violations.
227227 12 (a) Any covered pharmacy or retail distributor that
228228 13 violates this Act is guilty of a petty offense and subject to a
229229 14 fine of $500 for a first offense; $1,000 for a second offense
230230 15 occurring at the same retail location as and within 3 years of
231231 16 the offense; and $5,000 for a third or subsequent offense
232232 17 occurring at the same retail location as and within 3 years of
233233 18 the prior offenses.
234234 19 (b) An employee or agent of a covered pharmacy who
235235 20 violates this Act is guilty of a Class A misdemeanor for a
236236 21 first offense; a Class 4 felony for a second offense; and a
237237 22 Class 1 felony for a third or subsequent offense.
238238 23 (c) Any manufacturer that violates subsection (e) of
239239 24 Section 15 of this Act is guilty of a petty offense and subject
240240 25 to a fine of $500 for a first offense; $1,000 for a second
241241
242242
243243
244244
245245
246246 SB1875 - 6 - LRB104 09441 RLC 19501 b
247247
248248
249249 SB1875- 7 -LRB104 09441 RLC 19501 b SB1875 - 7 - LRB104 09441 RLC 19501 b
250250 SB1875 - 7 - LRB104 09441 RLC 19501 b
251251 1 offense occurring within 3 years of the first offense; and
252252 2 $5,000 for a third or subsequent offense occurring within 3
253253 3 years of the prior offenses.
254254 4 (Source: P.A. 97-670, eff. 1-19-12.)
255255
256256
257257
258258
259259
260260 SB1875 - 7 - LRB104 09441 RLC 19501 b